Notably, IGFBP-3 has been well-documented to show an inverse correlation with lung cancer [89], considering the lower levels of this IGFBP in the serum of patients vs. controls, as observed in several studies [90], suggesting it as a potential biomarker [87]. Here, IGFBP3 is linked to lung cancer.